TriSalus Life Sciences director buys 50,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TriSalus Life Sciences, Inc. director Mats Wahlstrom purchased 50,000 common shares directly at $2.24 per share on November 12, 2026, bringing his direct holdings to 197,555 shares. No Rule 10b5-1 plan is reported.
Separate indirect holdings were listed as 1,444,447 shares held by Leonard Capital LLC and 1,370,028 shares held by HW Investment Partners, LLC. Wahlstrom shares voting and investment discretion over Leonard Capital's shares with his spouse; he is a managing member of HW Investment Partners and shares discretion there, while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 50,000 | $2.24 | $112K |
| Holding | Common Stock F1 | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
Footnotes (2)
- F1. The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
- F2. The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
voting and investment discretion technical
beneficial ownership regulatory
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.